🔎 Trials Near Me

Hem › Akut myeloid leukemi › Nebraska › Omaha

Kliniska studier för Akut myeloid leukemi i Omaha, NE

10 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Omaha (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekryterarObservationsstudieFriska volontärer välkomna
  • Alegent Health Immanuel Medical Center, Omaha
  • Alegent Health Bergan Mercy Medical Center, Omaha
  • Alegent Health Lakeside Hospital, Omaha
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05554393

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • Children's Hospital and Medical Center of Omaha, Omaha
  • University of Nebraska Medical Center, Omaha
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • Children's Hospital and Medical Center of Omaha, Omaha
  • University of Nebraska Medical Center, Omaha
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RekryterarFas 1
  • University of Nebraska Medical Center, Omaha
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT06001788

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

RekryterarFas 2/3
  • University of Nebraska Medical Center, Omaha
Ålder 18 till 80 · Alla kön · Uppdaterad 5 aug. 2026 · NCT06788756

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • University of Nebraska Medical Center, Omaha
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

RekryterarFas 1/2
  • Nebraska Cancer Specialists, Omaha
  • University of Nebraska Medical Center, Omaha
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juni 2026 · NCT04068597

Akut myeloid leukemi-studier i andra städer

Andra studier i Omaha

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.